Southern tick-associated rash illness

Southern tick-associated rash illness
Name	Southern tick-associated rash illness
Caption	The Lone Star tick is the primary vector.
Field	Infectious disease
Symptoms	Expanding red rash, fatigue, headache, muscle pains, fever
Causes	Suspected bacterium related to Borrelia
Risks	Exposure to tick habitat in southeastern and south-central United States
Diagnosis	Based on symptoms, tick exposure, exclusion of other diseases
Differential	Lyme disease, STARI, Rocky Mountain spotted fever
Prevention	Tick avoidance, use of DEET, permethrin-treated clothing
Treatment	Antibiotics (e.g., doxycycline)
Prognosis	Excellent with treatment

Southern tick-associated rash illness is a condition associated with a tick bite and the subsequent development of an expanding red skin rash. The illness is transmitted by the bite of the Lone Star tick, a species prevalent in the southeastern and south-central United States. Its clinical presentation closely resembles early Lyme disease, but it is caused by a different, not yet fully characterized spirochete. Diagnosis is primarily clinical, and treatment typically involves a course of oral antibiotics, leading to rapid recovery.

Signs and symptoms

The hallmark sign is an expanding red, circular rash, often referred to as an erythema migrans-like lesion, which develops at the site of the tick bite. Patients frequently report accompanying symptoms such as fatigue, headache, muscle and joint pains, and fever. The rash associated with this illness may develop more rapidly and be of a smaller average size than the classic rash seen in Lyme disease caused by Borrelia burgdorferi. Unlike Lyme disease, chronic arthritic or neurological sequelae have not been documented following infection.

Cause and transmission

The causative agent is suspected to be a spirochete named Borrelia lonestari, though its definitive role in human disease requires further confirmation through CDC research. The primary vector for transmission is the Lone Star tick, specifically the nymph and adult female stages. This tick species is widely distributed across a range extending from Texas to New England and throughout the Southeastern United States. The white-tailed deer serves as a key reservoir host for the tick, facilitating the maintenance of the pathogen's life cycle in nature.

Diagnosis

Diagnosis is challenging and is primarily one of exclusion, based on clinical presentation and a history of potential exposure in an endemic area. There is no commercially available, FDA-approved blood test to confirm the infection. Physicians must rule out other tick-borne illnesses, particularly Lyme disease, Rocky Mountain spotted fever, and ehrlichiosis. The characteristic rash following a bite from a Lone Star tick in a region where Lyme disease is uncommon provides strong supportive evidence for the diagnosis.

Treatment

Empirical treatment with oral antibiotics is recommended and is highly effective. The drug of choice is typically doxycycline, which is also effective against other potential tick-borne pathogens like those causing Rocky Mountain spotted fever and ehrlichiosis. Alternative regimens may include amoxicillin or cefuroxime axetil. Prompt treatment usually leads to the rapid resolution of the rash and associated systemic symptoms, preventing potential complications.

Epidemiology

The illness occurs in geographic areas that correspond to the range of the Lone Star tick. Most cases are reported from states in the southeastern and south-central United States, including Missouri, North Carolina, Georgia, and Maryland. The incidence is likely underreported due to diagnostic uncertainties and its clinical similarity to Lyme disease. Cases are most frequent during the spring and summer months when tick activity is at its peak.

History and recognition

The condition was first formally described in the 1980s when patients in Missouri and other southern states presented with a Lyme disease-like rash but tested negative for Borrelia burgdorferi. Investigators from the CDC and universities like the University of Missouri began studying these cases. The association with the Lone Star tick and the provisional naming of the suspected pathogen, Borrelia lonestari, emerged from this research. It remains a condition of ongoing study within the field of vector-borne diseases.

Category:Tick-borne diseases Category:Diseases and disorders of the skin Category:Infectious diseases